Massimo Collino
Impact in
- Biochemistry top 0.5%
- Sulfur Compounds in Biology
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
Papers in
-
- Advanced Glycation End Products research 20
-
- Diet, Metabolism, and Disease 18
- Co-authors
- Christoph Thiemermann (54 shared papers)Roberto Fantozzi (35 shared papers)Fausto Chiazza (47 shared papers)Manuela Aragno (41 shared papers)Raffaella Mastrocola (37 shared papers)Elisa Benetti (25 shared papers)Nimesh S. A. Patel (22 shared papers)Margherita Gallicchio (10 shared papers)
- Journals
- Frontiers in Immunology (9 papers)Shock (7 papers)British Journal of Pharmacology (7 papers)Oxidative Medicine and Cellular Longevity (6 papers)Free Radical Biology and Medicine (6 papers)
- Partner nations
- ItalyUnited KingdomGermany
In The Last Decade
Massimo Collino
145 papers receiving 5.4k citations
Peers
Comparison fields: 5 of 128
- Biochemistry 497
- Clinical Biochemistry 432
- Nephrology 293
- Endocrinology, Diabetes and Metabolism 666
- Neurology 277
Countries citing papers authored by Massimo Collino
This map shows the geographic impact of Massimo Collino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Collino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Collino more than expected).
Fields of papers citing papers by Massimo Collino
This network shows the impact of papers produced by Massimo Collino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Collino. The network helps show where Massimo Collino may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Collino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 274 | |
| 2 | 2009 | 234 | |
| 3 | 2020 | 168 | |
| 4 | 2008 | 156 | |
| 5 | 2006 | 145 | |
| 6 | 2016 | 136 | |
| 7 | 2018 | 125 | |
| 8 | 2009 | 114 | |
| 9 | 2023 | 114 | |
| 10 | 2013 | 107 | |
| 11 | 2009 | 101 | |
| 12 | 2018 | 87 | |
| 13 | 2016 | 86 | |
| 14 | 2018 | 85 | |
| 15 | 2008 | 76 | |
| 16 | 2015 | 73 | |
| 17 | 2008 | 71 | |
| 18 | 2015 | 70 | |
| 19 | 2010 | 70 | |
| 20 | 2013 | 70 |
About Massimo Collino
Massimo Collino is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Immunology, Pathology and Forensic Medicine and Physiology, having authored 147 papers that have together received 5.5k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (20 papers), Diet, Metabolism, and Disease (18 papers), Cardiac Ischemia and Reperfusion (12 papers), Inflammasome and immune disorders (11 papers), Immune Response and Inflammation (11 papers), Sepsis Diagnosis and Treatment (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Peroxisome Proliferator-Activated Receptors (8 papers). The work is most often cited by research in Biochemistry (497 citations), Clinical Biochemistry (432 citations), Nephrology (293 citations), Endocrinology, Diabetes and Metabolism (666 citations) and Neurology (277 citations). Massimo Collino has collaborated with scholars based in Italy, United Kingdom and Germany. Frequent co-authors include Christoph Thiemermann, Roberto Fantozzi, Fausto Chiazza, Manuela Aragno, Raffaella Mastrocola, Elisa Benetti, Nimesh S. A. Patel, Margherita Gallicchio, Debora Collotta and Arianna Carolina Rosa. Their work appears in journals such as Frontiers in Immunology, Shock, British Journal of Pharmacology, Oxidative Medicine and Cellular Longevity and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.